Skip to main content
. 2024 Dec 18;28:413. doi: 10.1186/s13054-024-05204-7

Table 1.

Demographics, illness severity and comorbidities stratified by sex

Variable Overall n = 8950 Women n = 3811 Men n = 5139
Age 68.0 [56.0–79.0] 71.0 [58.0–81.0] 66.0 [54.0–77.0]
Comorbidity and Illness severity scores
 Charlson Comorbidity Index 5.0 [3.0–7.0] 5.0 [3.0–7.0] 5.0 [3.0–7.0]
 SAPS II 39.0 [31.0–49.0] 39.0 [31.0–50.0] 38.0 [30.0–49.0]
Diagnosis and admission type
 Sepsis at admission 6477 (72.4%) 2699 (70.8%) 3778 (73.5%)
 Type of admission
  Cardiac Vascular Intensive Care Unit (CVICU) 1077 (12.0%) 378 (9.9%) 699 (13.6%)
  Coronary Care Unit (CCU) 846 (9.5%) 322 (8.4%) 524 (10.2%)
  Medical Intensive Care Unit (MICU) 2320 (25.9%) 1003 (26.3%) 1317 (25.6%)
  Medical/Surgical Intensive Care Unit (MICU/SICU) 1202 (13.4%) 570 (15.0%) 632 (12.3%)
  Neuro Surgical Intensive Care Unit (Neuro SICU) 420 (4.7%) 183 (4.8%) 237 (4.6%)
  Neurology 702 (7.8%) 335 (8.8%) 367 (7.1%)
  Surgical Intensive Care Unit (SICU) 1239 (13.8%) 578 (15.2%) 661 (12.9%)
  Trauma SICU (TSICU) 1144 (12.8%) 442 (11.6%) 702 (13.7%)
ICU—treatment administered before delirium onset
 Invasive ventilation before onset of delirium 4593 (51.3%) 1843 (48.4%) 2750 (53.5%)
 Renal replacement therapy before onset of delirium 730 (8.2%) 306 (8.0%) 424 (8.3)
 Vasoactive medication* before onset of delirium 4039 (45.1%) 1665 (43.7%) 2374 (46.2%)
 Sedation with benzodiazepines before onset of delirium 2426 (27.1%) 993 (26.1%) 1433 (27.9%)
 Transfusion of pRBCs before onset of delirium 2576 (28.8%) 1159 (30.4%) 1417 (27.6%)
Comorbidities
 Peripheral vascular disease 1008 (11.3%) 382 (10.0%) 626 (12.2%)
 Coronary artery disease 1507 (16.8%) 533 (14.0%) 974 (19.0%)
 Cerebrovascular disease 1961 (21.9%) 923 (24.2%) 1038 (20.2%)
 Congestive heart failure 2478 (27.7%) 1057 (27.7%) 1421 (27.7%)
 Renal disease 1750 (19.6%) 645 (16.9%) 1105 (21.5%)
 Dementia 671 (7.5%) 346 (9.1%) 325 (6.3%)
 Chronic pulmonary disease 2226 (24.9%) 1104 (29.0%) 1122 (21.8%)
 Malignant cancer 1004 (11.2%) 386 (10.1%) 618 (12.0%)
 Rheumatic disease 276 (3.1%) 185 (4.9%) 91 (1.8%)
 Peptic ulcer disease 252 (2.8%) 107 (2.8%) 145 (2.8%)
 Mild liver disease 1201 (13.4%) 424 (11.1%) 777 (15.1%)
 Severe liver disease 630 (7.0%) 225 (5.9%) 405 (7.9%)
 Diabetes without complications 1981 (22.1%) 836 (21.9%) 1145 (22.3%)
 Diabetes with complications 916 (10.2%) 330 (8.7%) 586 (11.4%)
 Paraplegia 838 (9.4%) 388 (10.2%) 450 (8.8%)
 Metastatic solid tumor 449 (5.0%) 189 (5.0%) 260 (5.1%)
 Acquired immune deficiency syndrome (AIDS) 35 (0.4%) 10 (0.3%) 25 (0.5%)

For continuous variables medians with 25th–75th percentile in brackets are depicted, whereas for categorical variables absolute values and percent in brackets are presented

*Vasoactive medication was defined as infusion of dopamine, epinephrine, norepinephrine, phenylephrine, vasopressin, dobutamine or milrinone for at least 10 consecutive minutes or longer

AIDS Acquired immune deficiency syndrome; CCU Coronary Care Unit; CVICU Cardiac Vascular Intensive Care Unit; MICU Medical Intensive Care Unit; MICU/SICU Medical/Surgical Intensive Care Unit; Neuro SICU Neuro Surgical Intensive Care Unit; pRBCs Packed red blood cells; SAPS II Simplified Acute Physiology Score II; SICU Surgical Intensive Care Unit; TSICU Trauma SICU